Hsia‐Yuan Ying

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma”.

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0116

N/A

0DataRank · unranked

159 citations

Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain +24 more

Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage

Molecular Cell(2020)10.1016/j.molcel.2020.10.036

N/A

0DataRank · unranked

37 citations

Johannes C. Hellmuth, Rajat Singh, Hsia‐Yuan Ying, Lucy Skrabanek, Matthew Teater +5 more

Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.13.528351

N/A

0DataRank · unranked

5 citations

Christopher R. Chin, Hsia‐Yuan Ying, Cem Meydan, Matthew Teater, Min Xia +12 more

Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment

Nature Communications(2024)10.1038/s41467-024-47012-1

N/A

0DataRank · unranked

29 citations

Christopher R. Chin, Hsia‐Yuan Ying, Cem Meydan, Matthew Teater, Min Xia +19 more